Dren Bio
Clinical trials sponsored by Dren Bio, explained in plain language.
-
New hope for advanced cancers? early trial of DR-0202 begins
Disease control Recruiting nowThis early-phase study tests a new drug called DR-0202 in about 96 people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have not responded to at least two prior treatments. The main goal is to check the drug's safety and find the right dose. Participan…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New drug aims to regrow hair and restore skin color
Disease control Recruiting nowThis early-stage study tests a new drug called DR-01 in 80 adults with alopecia areata (patchy hair loss) or vitiligo (white patches on skin). The main goals are to check safety and see if the drug can improve hair regrowth and skin color. Participants will receive the drug and b…
Phase: PHASE1 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC